Skip to main content
. Author manuscript; available in PMC: 2021 Feb 11.
Published in final edited form as: Vaccine. 2019 Dec 20;38(7):1746–1752. doi: 10.1016/j.vaccine.2019.12.028

Table 2.

History of hypersensitivity and exposure to known triggers among U.S. reports of Erythema Multiforme (EM), Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), or SJS/TEN to VAERS, 1999–2017.

EM (%), (n = 984) SJS (%), (n = 89) SJS/TEN (%), (n = 6) TEN (%), (n = 7) Total, N = 1086
Infection, no. (%)
Yes 4 (<1) 2 (2) 0 (0) 0 (0) 6 (1)
No 980 (>99) 87 (98) 6 (100) 7 (100) 1080 (99)
Medication,a no. (%)
Anticonvulsant 1 (<1) 5 (6) 0 (0) 2 (29) 8 (1)
Antibiotics
Sulfa drugs 4 (<1) 3 (3) 0 (0) 1 (14) 8 (1)
Penicillin 52 (5) 3 (3) 1 (17) 0 (0) 56 (5)
Macrolides 6 (1) 3 (3) 0 (0) 0 (0) 4 (<1)
NSAIDsb 11 (1) 6 (7) 0 (0) 0 (0) 8 (1)
Acetaminophen 5 (1) 5 (6) 0 (0) 0 (0) 10 (1)
Existing/history of hypersensitivity,a no., (%)
EM-SJS-TEN 6 (1) 5 (6) 0 (0) 0 (0) 11 (1)
Atopic dermatitis 25 (3) 2 (2) 1 (17) 1 (14) 29 (3)
Respiratory allergiesc 47 (5) 4 (4) 0 (0) 1 (14) 52 (5)
Drug allergy
Anticonvulsant 0 (0) 1 (1) 0 (0) 0 (0) 1 (<1)
Antibiotics
Sulfa drugs 8 (1) 2 (2) 0 (0) 0 (0) 10 (1)
Penicillin 27 (3) 6 (7) 1 (17) 0 (0) 34 (3)
Macrolide 7 (1) 0 (0) 1 (17) 0 (0) 8 (1)
NSAIDs 4 (<1) 3 (3) 0 (0) 0 (0) 7 (1)
Acetaminophen 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
a

Not mutually exclusive.

b

NSAID = non-steroidal anti-inflammatory drug.

c

Includes asthma/reactive airway disease, allergic sinusitis, and allergic bronchitis.